Advanced search
Publication Cover
Expert Opinion on Therapeutic Patents Volume 10, 2000 - Issue 6
Submit an article Journal homepage
32
Views
0
CrossRef citations to date
0
Altmetric
Review

Human T-cell Kv1.3 potassium channel blockers: new strategies for immunosuppression

Amy Lew Department of Chemistry, University of California, Irvine, CA 92697, USA
&
A Richard Chamberlin Department of Chemistry, University of California, Irvine, CA 92697, USA
Pages 905-915 | Published online: 25 Feb 2005

Bibliography

  • SCHREIBER SL, CRABTREE GR: The mechanism of actionof cyclosporin A and FK506. Immunol. Today (1992) 13:136–142.
  • SCHREIBER SL: Chemistry and biology of the immuno-philins and their immunosuppressive ligands. Science (1991) 251:283.
  • DURMONT FJ, SU Q: Mechanism of action of theimmunosuppressant rapamycin. Life Sci. (1996) 58:373–395.
  • HUGHES SE, GRUBER SA: New immunosuppressivedrugs in organ transplantation. J. Olin. Pharmacol (1996) 36:1081–1092.
  • DURMONT FJ, STARUCH MJ, KOPRAK SL et al.: Theimmunosuppressive and toxic effects of FK-506 are mechanistically related: pharmacology of a novel antagonist of FK-506 and rapamycin. J. Exp. Med. (1992) 176:751–760.
  • ROITT I, BROSTOFF J, MALE D: Transplantation andrejection. In: Immunology 4th Ed. London, UK (1996):26.1–26.13.
  • •Good general review on organ transplantation.
  • LEWIS RS, CAHALAN MD: Potassium and calcium in lymphocytes. Ann. Rev. Immunol. (1995) 13:623–653.
  • •Good general review on ion channels in T-cells.
  • DECOURSEY TE, CHANDY KG, SUDHIR G, CAHALAN MD:Voltage gated potassium channels in human T lymphocytes: a role in mitogenesis? Nature (1984) 307:465.
  • CHANDY KG, DECOURSEY TE, CAHALAN MD: Voltage-gated channels are required for human T lymphocyte activation. J. Exp. Med. (1984) 160:369–385.
  • UN CS, BOLTZ RC, BLAKE JT et al: Voltage-gated potassium channels regulate calcium dependent pathways involved in human T lymphocyte activation. J. Exp. Med. (1993) 177:637–645.
  • KOO GC, BLAKE JT, TALENTO A et al: Blockade of the voltage-gated potassium channel kv1.3 inhibits immune responses in vivo. J. Immunol. (1997) 22:5120–5128.
  • •The first demonstration that a Kv1.3 channel blocker functions as an immunosuppressant in vivo.
  • GRISSMER S, NGUYEN AN, AIYAR J et al.: Pharma-cological characterization of five cloned voltage-gated K± channels, types Kv1.1, 1.2, 1.3,1.5 and 3.1, stably expressed in mammalian cell lines. Mol. Pharmacol. (1994) 45:1227–1234.
  • AIYAR J, WITHKA JM, RIZZI JP et al.: Topology of the pore-region of a K± channel revealed by the NMR-derived structures of scorpion toxins. Neuron (1995) 15:1169.
  • •Early model of the Kv1.3 channel vestibule.
  • AIYAR J, RIZZI JP, GUTMAN GA, CHANDY KG: The signature sequence of voltage-gated potassium channels projects into the external vestibule. J. Biol. Chem. (1996) 271:31013.
  • •Updated model of the Kv1.3 channel vestibule.
  • SPENCER RH, SOKOLOV Y, LI H et al.: Purification, visualization and biophysical characterization of Kv1.3 tetramers. J. Biol. Chem. (1997) 272:2389–2395.
  • LOGSDON N, KANG J, TOGO J et al.: A novel gene, hKCa4, encodes the calcium-activated potassium channel in human T lymphocytes. J. Biol. Chem. (1997) 272:32723–32726.
  • FANGER CM, GHANSHANI S, LOGSDON NJ et al.: Calmodulin mediates calcium-dependent activation of the intermediate conductance Ica channel, 'Kcal. .1 Biol. Chem. (1999) 274:5746–5754.
  • RAUER H, PENNINGTON M, CAHALAN M, CHANDY KG: Structural conservation of the pores of calcium-activated and voltage-gated potassium channels determined by a sea anemone toxin. J. Biol. Chem. (1999) 274:21885–21892.
  • CHANDY KG, GUTMAN GA: Voltage-gated potassium channel genes. In: Handbook of Receptors and Channels: Ligand and Voltage Gated ion Channels. CRC Press, Boca Raton, FL, USA (1995):1–71.
  • ••Good review on voltage-gated K.+ channels.
  • CHANDY KG, STRONG M, AIYAR J, GUTMAN GA: Structural and biochemical features of the Kv1.3 potassium channel: an aid to guided drug design. Cell. Physiol. Biochem. (1997) 7:135–147.
  • •Good review on targeting Kv1.3 channels for immunosup-pressant development.
  • GUY HR: Models of voltage-and transmitter-activated channels based on their amino acid sequences. In: Monovalent Cations in Biological Systems. CRC Press, Boca Raton, FL, USA (1990):31–58.
  • GUY HR, DURELL SR: Using homology in modeling the structure of voltage-gated ion channels. In: Molecular of Physiological Processes. Rockefeller University Press, New York, USA (1994):197–212.
  • GUY HR, DURELL SR: Structural model of Nat, Ca2+ andK± channels. In: Ion Channels and Genetic Diseases. The Rockefeller University Press, New York, USA (1995):1–16.
  • DOYLE DA, CABRAL J, PFUETZNER RA et al.: The structure of the potassium channel: molecular basis of K± conduction and selectivity. Science (1998) 280:69–77.
  • ••X-ray crystal structure of the KcsA bacterial K.+ channel.
  • PRICE M, LEE SC, DEUTSCH C: Charybdotoxin inhibitsproliferation and interleukin-2 production in human peripheral blood lymphocytes. Proc. Natl. Acad. ScL USA (1989) 86:10171–10175.
  • LEONARD RJ, GARCIA ML, SLAUGHTER RS, REUBEN JP:Selective blockers of voltage-gated K± channels depolarize human T lymphocytes: mechanism of antiproliferative effect of charybdotoxin. Proc. Natl. Acad. ScL USA (1992) 89:10094–10098.
  • GARCIACALVO M, LEONARD R, NOVICK J et al.: Purifica-tion, characterization and biosynthesis of margatoxin, a component of centruroides-margaritatus venom that selectively inhibits voltage-dependent potassium channels. J. Biol. Chem. (1993) 1993:18866–18874.
  • HELMS L, FELIX J, BUGIANESI R et al.: Margatoxin bindsto a homomultimer of Kv1.3 channels in jurkat cells. Comparison with Kv1.3 expressed in CHO cells. Biochem. (1997) 36:3737–3744.
  • CREST M, JACQUET G, GOLA M et al.: Kaliotoxin, a novelpeptidyl inhibitor of neuronal BK-Type Ca2±-activated K± channels characterized from Androctonus mauretanicus venom. J. Biol. Chem. (1 9 9 2) 267:1640-1647.
  • ROMI R, CREST M, GOLA M et al.: Synthesis and charac-terization of kaliotoxin - Is the 26-32 sequence essential for potassium channel recognition? J. Biol. Chem. (1993) 268:26302–26309.
  • MOURRE C, CHERNOVA M, MARTIN-EAUCLAIRE M et al.:Distribution in rat brain of binding sites of kaliotoxin, a blocker of Kv1.1 and Kv1.3 alpha-subunits. J. Pharm. Exp. Ther. (1999) 291:943–952.
  • TUDOR JE, PALLAGHY PK, PENNINGTON MW, NORTONRS: Solution structure of ShK toxin, a novel potassium channel inhibitor from a sea anemone. Nature Struc. Biol. (1996) 3:317–320.
  • KALMAN K, PENNINGTON MW, LANIGAN MD et al.: ShK-Dap22, a potent Kv1.3-specific immunosuppres-sive polypeptide. J. Biol. Chem. (1998) 273:32697–32707.
  • DURELL S, HAO Y, GUY H: Structural models of thetransmembrane region of voltage-gated and other K± channels in open, closed and inactivated conforma-tions. J. Struc. Biol. (1998) 121:263–284.
  • LEW A, CHAMBERLIN AR: Blockers of human T cellKv1.3 potassium channels using de novo ligand design and solid phase parallel combinatorial chemistry. Bio. Org. Med. Chem. Lett. (1999) 9:3267–3272.
  • HILL RJ, GRANT AM, VOLBERG W et al: Win 17317-3: nonpeptide antagonist of voltage-activated K± channels in human T lymphocytes. Mol. Pharm. (1995) 48:98.
  • WANNER S, GLOSSMANN H, KNAUS H: WIN17317-3, a new high-affinity probe for voltage-gated sodium channels. Biochem. (1999) 38:11137–11146.
  • NGUYEN A, KATH JC, HANSON DC et al.: Novel nonpep-tide agents potently block the C-type inactivated conformation of Kv1.3 and suppress T cell activation. Mol Pharm. (1996) 50:1672.
  • BURGESS LE, KOCH K, COOPER K et al.: The SAR of UK-78,282: a novel blocker of human T cell Kv1.3 potassium channels. Bioorg. Med. Chem. Lett. (1997) 7:1047–1052.
  • HANSON D, NGUYEN A, MATHER R et al: UK-78,282, anovel piperidine compound that potently blocks the Kv1.3 voltage-gated potassium channel and inhibits human T cell activation. British J. Pharm. (1999) 126:1707–1716.
  • GOETZ MA, HENSENS OD, ZINK DL et al.: Potent nor-triterpenoid blockers of the voltage-gated potassium channel Kv1.3 from Spachea correae. Tetrahedron Lett. (1998) 39:2895–2898.
  • HANNER M, SCHMALHOFER WA, GREEN B et al: Binding of correolide to the Kvl family potassium channels. J. Biol. Chem. (1999) 274:25237–25244.
  • FELIX JP, BUGIANESI RM, SCHMALHOFER, WA et al: Identification and biochemical characterization of a novel nortriterpene inhibitor of the human lympho-cyte voltage-gated potassium channel, Kv1.3. Biochem-istry (1999) 38:4922–4930.
  • KOO GC, BLAKE JT, SHAH K et al.: Correolide and deriva-tives are novel immunosuppressants blocking the lymphocyte Kv1.3 potassium channels. Cell. Immunol. (1999) 197:99–107.
  • •Correolide analogues are immunosuppressive in vivo and do not block the Kca channels in human T-cells.
  • BAO JM: Correolide derivatives. 218th American Chemical Society Meeting, New Orleans, Louisiana, USA (1999).
  • ALESSANDRI-HABER N, LECOQ A, GASPARINI S et al.: Mapping the functional anatomy of BgK on Kv1.1, Kv1.2 and Kv1.3: clues to design analogs with enhanced selectivity. J. Biol. Chem. (1999) 274:35653–35661.
  • •Studies of the topographies of closely related Kvl isoforms.

Websites

  • United Network For Organ Sharing Website; http://www.unos.org/ (May 2000).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.